Frankfurt - Delayed Quote EUR

Jolt Health Inc. (IY7.F)

Compare
0.0005 0.0000 (0.00%)
As of April 16 at 8:00 AM GMT+2. Market Open.
Loading Chart for IY7.F
DELL
  • Previous Close 0.0005
  • Open 0.0005
  • Bid --
  • Ask --
  • Day's Range 0.0005 - 0.0005
  • 52 Week Range 0.0005 - 0.0136
  • Volume 8,500
  • Avg. Volume 0
  • Market Cap (intraday) 430,804
  • Beta (5Y Monthly) 1.52
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada, the Netherlands, rest of Europe, and Jamaica. The company focuses on sexual health, with or without the benefit of CBD, acquired pursuant to various licenses. It offers CannaStrip, an oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits; Arousel Gel, a topical gel infused with CBD and/or THC that increases genital blood flow causing vaginal engorgement/lubrication and clitoral engorgement/sensitivity; and CannaMint, a patent-protected technology that uses orally dissolvable mints to deliver CBD or THC for a variety of conditions. The company also provides female sexual dysfunction supplement, a female sexual desire supplement; ToConceive, a vaginal moisturize; and male enhancement gel with CBD, a topical personal care penile gel. The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023. Jolt Health Inc. is headquartered in Vancouver, Canada.

jolt-health.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IY7.F

Performance Overview: IY7.F

Trailing total returns as of 6/12/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IY7.F
0.00%
S&P/TSX Composite index
4.79%

1-Year Return

IY7.F
95.00%
S&P/TSX Composite index
10.40%

3-Year Return

IY7.F
99.87%
S&P/TSX Composite index
9.05%

5-Year Return

IY7.F
97.50%
S&P/TSX Composite index
35.16%

Compare To: IY7.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IY7.F

Valuation Measures

Annual
As of 6/12/2024
  • Market Cap

    430.80k

  • Enterprise Value

    533.31k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.65

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -27.59%

  • Return on Equity (ttm)

    -584.64%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -689.83k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    273.79k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -57.96k

Research Analysis: IY7.F

Company Insights: IY7.F

Research Reports: IY7.F